Pence, top congressional leaders get vaccines
WASHINGTON — Vice President Mike Pence and the leaders of the House and Senate received their first doses of the COVID-19 vaccine on Friday as they tried to reassure the American public that the shot is safe. Pence, in a live-television event, celebrated the milestone as “a medical miracle” that could eventually put an end to a raging pandemic that has killed more than 310,000 people nationwide.
“I didn’t feel a thing. Well done,” Pence told the technicians from Walter Reed National Military Medical Center on Friday morning as he became the highest-ranking U.S. official to receive the PfizerBioNTech shot, the first authorized in the U.S.
Later, House Speaker Nancy Pelosi, a Democrat, and Senate Majority Leader Mitch McConnell, a Republican, tweeted photos of themselves receiving the vaccine from the Capitol physician, who urged all members of Congress to join them.
The public displays come as top U.S. health officials are trying to persuade regular Americans who may be skeptical of the vaccinations to get them to pave the way for the end of the pandemic.
A recent survey from The Associated Press-NORC Center for Public Affairs Research found that only about half of Americans want to get the vaccine as soon as possible. Another quarter of the public isn’t sure, while the remaining quarter say they aren’t interested. Some simply oppose vaccines in general. Others are concerned that the injections have been rushed and want to see how the rollout goes.
Trump, who was hospitalized with COVID19 in October, has been largely absent from the effort to sell the American public on what aides hope will be a key part of his legacy. He has held no public events to trumpet the rollout. He hasn't said when he will be inoculated. And he has tweeted fewer than a handful of times about the shot despite sending a flurry of tweets about other topics.
Trump’s relative silence comes as he continues to rage about his defeat in the Nov. 3 election and embraces increasingly extreme efforts to overturn the people’s will. He’s pushed aside the plans of aides who wanted him to be the public face of the vaccination campaign, eschewing visits to labs and production facilities to thank workers, or hosting efforts to build public confidence in the shot, according to people familiar with the conversations who spoke on condition of anonymity to speak candidly.
Instead, Pence has been the one in the spotlight highlighting the safety and efficacy of the vaccines, touring a production facility this week before headlining Friday's event.
Pence didn’t flinch during the quick prick, nor did his wife, Karen. Surgeon General Jerome Adams, who is Black, also received a shot during the televised White House event and stressed the importance of communities of color seeing people like him being vaccinated to build trust.
“Today, Karen and I wanted to step forward and take this vaccine to assure the American people that while we cut red tape, we cut no corners," Pence said. “Hope is on the way."
Trump's lack of visibility has been surprising, especially for a president rarely shy to take credit, said Lawrence Gostin, a professor at Georgetown Law who focuses on public health.
“The president’s relatively low profile on the COVID response since the election is curious and counter to Mr. Trump’s own interests,” he said. Gostin, who has criticized Trump's handling of the pandemic in the past, said that he “deserves a great deal of credit" for Operation Warp Speed and placing a bet on two vaccines that use groundbreaking mRNA technology.
“Having exhibited leadership in the vaccines’ development, he should take great pride in publicly demonstrating his trust in COVID vaccines," he said.
Trump did appear at a White House “summit” ahead of the Food and Drug Administration's approval of the Pfizer vaccine last week. But many Trump aides are puzzled by his low profile now that the vaccine is actually being injected. They see it as a missed opportunity for the president, who leaves office on Jan. 20, to claim credit for helping oversee the speedy development and deployment of the vaccine that is expected to finally contain the virus.